SynBiotic SE Registered Shares SBX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €8.92
- Day Range
- €9.30–9.70
- 52-Week Range
- €2.88–42.80
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €49.80 Mil
- Volume/Avg
- 500 / 67,601
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 104
- Website
- https://www.synbiotic.com
Valuation
|
Metric
|
SBX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SBX
|
|---|---|
Quick Ratio | 0.61 |
Current Ratio | 1.40 |
Interest Coverage | −138.43 |
Quick Ratio
SBX
Profitability
|
Metric
|
SBX
|
|---|---|
Return on Assets (Normalized) | −46.70% |
Return on Equity (Normalized) | −66.43% |
Return on Invested Capital (Normalized) | −60.90% |
Return on Assets
SBX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rvmmlwkhw | Pksw | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Cjtnfzmgl | Fhrjg | $70.8 Bil | |
HLN
| Haleon PLC ADR | Sdbgsdyz | Nmy | $38.2 Bil | |
VTRS
| Viatris Inc | Hvrnxwtb | Vjtjz | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tgxvkkd | Tpmx | $12.5 Bil | |
CTLT
| Catalent Inc | Rygpzqtt | Psgckwn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Lvwybnpcd | Kpzly | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Hqrqkjbm | Xqz | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dgmhrzjh | Zylkly | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Dgxylfgv | Ftk | $2.9 Bil |